Looking for The right place in Europe for clinical trials?
All the right conditions
Continuous optimization of clinical trial processes and procedures, a highly-skilled workforce, excellent hospitals and researchers, and much more, makes Denmark a very attractive place for international pharmaceutical companies wanting to conduct clinical research and trials.
Denmark is an increasingly attractive location for businesses that depend on clinical trials. In recent years, the various Danish governments have taken active steps to boost the life sciences industry by building on the already strong national healthcare system and world-class environment for business and science. This also includes a keen political focus on improving the framework conditions for conducting clinical trials in Denmark.
Most recently, the Danish government has presented a new Danish Life Science Strategy comprising 38 initiatives, of which eighteen of the initiatives aims to the framework conditions for clinical trails such as:
- lowering the fees associated with clinical trials.
- bringing down approval time for clinical trials, already among the fastest in Europe.
- initiating a new pilot project on virtual clinical trials, and lastly.
- making patient data more accessible.
National entry point for companies
To make it easier and more attractive for global companies to conduct clinical trials in Denmark, a single entry point named Trial Nation was established in 2018. The services of Trial Nation includes:
- Investigator identification.
- A coordinated feasibility process with a national response from hospital sites within five days.
- Access to Trial Nations legal network offering legal advice and national contract negotiations.
- Access to established clinical specialty centers and national networks within oncology, hematology, dermatology, pediatrics, respiratory diseases, infectious diseases and dementia.
- And access to established partnerships with hospitals, scientists and patient networks – all free of charge.
Trial Nation has also a focus on clinical trials within the MedTech industry.
Decentralised clinical trials
A current topic within clinical trials is ‘decentralised clinical trials’. This is also the case for the Danish Medicines Agency (DKMA), which actively is supporting the development in decentralised clinical trials. The Agency has started a project with the aim of ensuring a contemporary and robust regulatory framework for digitalisation and decentralisation of clinical trials. Through this commitment, Denmark will maintain its strong position in clinical research for the benefit of patients. DKMA encourage sponsors to contact them and initiate a dialogue about all decentralised trials.
Furthermore, they wish to collaborate on conduction of pilot projects with elements of decentralised clinical trials. To ensure strong interactions between authorities, patients, researchers, and the industry, DKMA and Trial Nation have set up a forum for dialogue on decentralised clinical trials. The forum provides opportunity for discussion of views, barriers, and experiences with DCT and of regulatory processes, which are not framed at present.
Top 10 Reason for why your company should conduct clinical trials in Denmark:
get more information on Trial Nation
Trial nation
Visit their website for more information
For more information on the disease specific centers under Trial Nation:
- Center for Dementia: TRIAL-NATION-DEMENTIA_Updated-22.06.2020.pdf
- Center for Dermatology: TRIAL-NATION-DERMATOLOGY_Updated-22.06.2020.pdf
- Center for Haematology: Hematology-folder_v.2.pdf (trialnation.dk)
- Center for Infectious Disease & Immune Modulation: TRIAL-NATION-INFECTIOUS-DISEASE_Updated-17.6.2020.pdf
- Center for Oncology: TRIAL-NATION-ONCOLOGY.pdf (trialnation.dk)
- Center for Respiratory Medicine: TRIAL-NATION-RESPIRATORY-MEDICINE_Updated-23.09.2020.pdf
- Center for MedTech (all therapeutic areas): Trial Nation
get in touch Want to know more about clinical trials in Denmark?
Please contact our dedicated life science experts here: